Euroapi SAS (EAPI) EUR1

Sell:€3.19Buy:€3.20€0.01 (0.37%)

Prices delayed by at least 15 minutes
Sell:€3.19
Buy:€3.20
Change:€0.01 (0.37%)
Prices delayed by at least 15 minutes
Sell:€3.19
Buy:€3.20
Change:€0.01 (0.37%)
Prices delayed by at least 15 minutes

Company Information

About this company

Euroapi SAS is a France-based company. The Company is engaged in the development, manufacture and supply of active-ingredient solutions to its healthcare partners. It offers vitamin B12, prostaglandins, oligonucleotides, peptides, corticoids and hormones, anti-infectives, opiates (morphine, codeine, thebaine, etc.), analgesics, etc. The Company also provides technologies and develops molecules through it’s Contract Development and Manufacturing Organization (CDMO). It’s CDMO services include Tides, Prostaglandins, Particle Engineering, Microbial Fermentation, Small Molecules Synthesis, Steroids and Hormones and Opiates & Controlled Substances. It has production sites located in France, the United Kingdom, Germany, Italy and Hungary.

Key people

Emmanuel Blin
Chair of the Board
David Seignolle
Chief Executive Officer
Olivier Falut
Chief Financial Officer
Marion Santin
Chief Legal, Compliance, and IP Officer
Guillaume Rosso
Chief Commercial Officer
Olivier Klaric
Representative of Sanofi Aventis Participations
Guillaume Mortelier
Representative of Bpifrance Investissement
Marie-Isabelle Penet
Representative of Employees
Kevin Rodier
Representative of Employees
Elizabeth A. Bastoni
Independent Director
Click to see more

Key facts

  • EPIC
    -
  • Location
    France
  • Sector
    Healthcare
  • Industry
    Biotechnology & Drugs
  • ISIN
    FR0014008VX5
  • Market cap
    €306.08m
  • Employees
    3,669
  • Shares in issue
    95.59m
  • Exchange
    Euronext Paris
  • Index

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.